ALISO VIEJO, CA, – September 29, 2011 – Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry’s staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches.…

LEXINGTON, Mass., – September 20, 2011 – RainDance Technologies, Inc., the Digital Biology™ company, today announced that Ambry Genetics has purchased the company’s new ThunderStorm™ System for genetic testing and next-generation targeted sequencing services. Launching next month, RainDance’s ThunderStorm System is a fully-automated and walkaway high-throughput targeted sequencing solution that enables researchers to process 96 samples…

LEXINGTON, Mass., – September 20, 2011 – RainDance Technologies, Inc., the Digital Biology™ company, today announced that Ambry Genetics has purchased the company’s new ThunderStorm™ System for genetic testing and next-generation targeted sequencing services. Launching next month, RainDance’s ThunderStorm System is a fully-automated and walkaway high-throughput targeted sequencing solution that enables researchers to process 96 samples…

ALISO VIEJO, CA – August 31, 2011 – Ambry Genetics today introduces their new CancerArray™ product and services utilizing aCGH technology. The Ambry CancerArray™ is a high resolution exon-focused 180K array offering genome-wide probe coverage with higher probe density coverage in over 400 known cancer-associated genes. The array enhances the resolution in these functionally important cancer…

MADISON, Wisc., New York, NY and ALISO VIEJO, Calif. – June 15, 2011 – Cell Line Genetics, Inc., a leader in Stem Cell Quality Assurance services and products, and Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announced today an exclusive agreement under which Cell Line Genetics…

Aliso Viejo, CA – April 19, 2011 – Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become a Certified Service Provider (CSP) for NimbleGen Comparative Genomic Hybridization (CGH), Chromatin Immunoprecipiation-on-chip (ChIP-chip), DNA Methylation and Gene Expression. The addition of these applications means…

Aliso Viejo, CA – April 4, 2011 – Ambry Genetics announced today that it is the first authorized customer service provider (CSP) in Ion Torrent’s new service provider program. Ion Torrent’s CSP certification assures customers that the organization they are trusting with their samples has been trained and tested by Ion Torrent to produce the…

CENTENNIAL, CO and ALISO VIEJO, CA, March 15, 2011 – LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries,…

Washington, D.C. – March 7, 2011 – RainDance Technologies, Inc. and Ambry Genetics, today announced a new collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion (ADME) genetic screening panel for use on next-generation sequencing (NGS) systems. The announcement was made in conjunction with the Society of Toxicology’s…

Aliso Viejo, CA – December 9, 2010 – Ambry Genetics, a global leader in genomic services to the healthcare and life sciences industries, announced today that it has officially launched their Illumina HiSeq 2000 Next Generation Sequencing Services. Ambry Genetics has been an early adapter of Illumina sequencing systems since 2007 and has extensive experience…